Erie's Public Schools and Zurn Elkay Water Solutions Announce Donation for Cleaner, Healthier, Safer Drinking Water
This summer Erie's Public Schools (EPS) will install 50 donated Elkay filtered bottle filling stations in nine elementary schools and convert all faucets at the district's Culinary Center, ensuring cleaner, healthier, safer drinking water.
Donated Elkay filters are tested and certified to reduce lead, PFAS, microplastics and other harmful contaminants.
Donation is part of Zurn Elkay's yearlong celebration of the 125th anniversary of the company's founding in Erie, home to 160 associates and three manufacturing and R&D facilities.
ERIE, Pa., May 22, 2025--(BUSINESS WIRE)--Zurn Elkay Water Solutions Corporation (NYSE: ZWS) and Erie's Public Schools (EPS) today announced the donation of 50 Elkay filtered bottle filling stations, eight filter conversion kits and five years of Elkay filters for each of the donated units, ensuring consistent delivery of cleaner, healthier, safer drinking water to students, faculty, staff and community members.
In an event at EPS's JoAnna Connell Elementary School, 1820 E. 38th Street, Mayor Joseph V. Schember, incoming EPS Superintendent Natalyn Gibbs, EdD, and Zurn Elkay Chairman and CEO Todd A. Adams celebrated the donation with a class of first-grade students. This summer, the donated units will be installed across nine EPS elementary schools, replacing unfiltered drinking fountains with one filtered bottle filling station per 100 students; EPS has four Elkay filtered bottle filling stations already slated for installation at the new Edison Elementary School, set to open in Fall 2025. Additionally, all faucets in EPS's Culinary Center will be retrofitted to Elkay filtration, using donated conversion kits and filter cartridges.
"As an urban school district that serves roughly 10,000 students and their families, it is important that Erie's Public Schools is a leader in the charge to provide access to clean, lead-free water," Dr. Gibbs said. "We are so grateful to our partners at Zurn Elkay Water Solutions for their incredibly generous donation, which helps us deliver the kind of healthy school environments that students need to thrive."
Elkay filters are tested and certified to NSF/ANSI 42, 53 and 401 to reduce lead, PFAS (PFOA/PFOS), microplastics and other harmful contaminants. Since 2012, the use of Elkay bottle filling stations has eliminated the need for more than 103 billion single-use plastic bottles.
"For kids across the country, including right here in Erie, school buildings are more than just places for learning and social growth—they're also a vital source of drinking water," said Adams. "Elkay filtered bottle filling stations and drinking fountains are an immediate and cost-effective solution to expensive and laborious infrastructure upgrades. We are so proud of our Erie heritage and that is why we are making this donation to help ensure that students, teachers and staff members have access to cleaner, healthier, safer drinking water."
The donation is part of Zurn Elkay's yearlong celebration of the 125th anniversary of the company's founding in Erie. In 1900, the ambitious 26-year-old John A. Zurn purchased the patent and casts for a backwater valve from the local foundry and set up shop in his mother's barn in Erie. His entrepreneurial spirit, quest for growth and commitment to meeting—and exceeding—his customers' needs formed the foundation of today's Zurn Elkay Water Solutions. During the week of May 19-23, the company is commemorating the milestone with employee celebrations at its more than two dozen locations across the United States, including in Erie, where more than 160 associates are based.
"For 125 years Zurn Elkay's associates have contributed to Erie's enduring legacy as a city that balances its commitment to its people, the potential of its industry, and the preservation of its natural resources," Mayor Schember said, issuing a proclamation of May 22, 2025, as "Zurn Elkay Water Solutions Day" in the City of Erie. "We are fortunate to have such a successful business in Erie, and I wish Zurn Elkay many more years of continued success."
"John A. Zurn had the vision and the drive to prevent contamination of water sources… but he didn't do it alone," Adams added. "He had a family, friends, partners and a community to support him, and we're honored to have been part of that community for 125 years."
For photos and video from today's announcement, please visit
zurnelkay.com/press-room/press-kits.
About Erie's Public Schools
Erie's Public Schools consists of 16 schools that serve approximately 10,000 students each day. By actively engaging students in their learning through a high-quality, Common Core-aligned curriculum and excellent teaching, Erie's Public Schools is raising expectations and creating a culture of high expectations, collaboration, respect and accountability. Our primary objective is to prepare city students to establish and achieve their higher education and career goals. We invite you to explore www.eriesd.org to discover how the district is partnering with families and the community to improve students' lives.
About Zurn Elkay Water Solutions
Named one of America's Most Responsible Companies and one of America's Greenest Companies by Newsweek and one of the World's Best Companies for Sustainable Growth by TIME, Zurn Elkay Water Solutions is headquartered in Milwaukee, WI, and is a growth-oriented, pure-play water management business that designs, procures, manufactures and markets what we believe to be the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. The Zurn Elkay product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products and filtered drinking water products for public and private spaces. Learn more at www.zurnelkay.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250522129749/en/
Contacts
Erica Erwin, Coordinator - PR & Strategic CommunicationsErie's Public Schoolseerwin@eriesd.org / 814-874-6035
Angela Hersil, VP - Corporate CommunicationsZurn Elkay Water Solutionscorporate.communications@zurnelkay.com / 855-480-5050
Kyle Hannon, Director - CommunicationsCity of Eriekhannon@erie.pa.us / 814-870-1285
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
Is Hims & Hers Health a Smart Buy Right Now?
Hims & Hers is the newest darling disrupting the telemedicine space. While shares have jumped 157% over the last year, Wall Street analysts don't seem overly bullish on the stock. Despite impressive results in the business, Hims & Hers has a high short interest -- making a short-squeeze a possibility. 10 stocks we like better than Hims & Hers Health › When it comes to stocks that continue to beat the market, my guess is that your mind goes straight to companies leading the charge in artificial intelligence (AI). Sure, stocks such as Palantir Technologies or CoreWeave remain red-hot in a strong technology sector. But smart investors understand that there are myriad opportunities beyond the usual suspects in tech. One company that has emerged as a new favorite among investors is telemedicine business Hims & Hers Health (NYSE: HIMS). With shares up 157% over the last 12 months as of market close June 4, Hims & Hers Health looks like the next monster growth stock at the intersection of healthcare and technology. Let's assess the state of Hims & Hers' business and then take a look at what Wall Street thinks. Is buying shares of this telemedicine darling a good idea right now? Read on to find out. Hims & Hers is a telemedicine platform that offers patients access to a variety of medications, including for skin care, anxiety, sexual health, and even weight loss. At the core of the company's business model is a subscription platform. At the end of the first quarter, Hims & Hers boasted 2.4 million subscribers, which represented an increase of 38% year over year. This translated into revenue of $586 million for the quarter, up by a jaw-dropping 111% year over year. By keeping its business primarily online, Hims & Hers can benefit in a couple of ways. First, subscription revenue is recurring and therefore carries high gross margins. Second, by keeping its user base using its offerings, the company has the flexibility to spend less on marketing and invest in other areas, such as technology or research and development, in an effort to bolster customer acquisition strategies. Per management's vision, Hims & Hers is doubling down on investments in AI to get a better sense of its customer data. This could be a savvy move, as it may help the company unlock new expansion opportunities. While the ideas above paint a picture of a fast-growing, disruptive new solution in the healthcare space, Wall Street doesn't seem totally sold on Hims & Hers just yet. Over the last month, a number of equity research analysts, including Piper Sandler, Citigroup, Bank of America, and Morgan Stanley, have each maintained ratings of neutral, sell, underperform, or equal-weight. Another way of looking at this is that among some of the largest banks on Wall Street, none seem to have a compelling buy rating on Hims & Hers stock. In addition, the average price estimate among analysts for Hims & Hers stock is roughly $48, implying 12% downside from trading levels as of June 4. Given Wall Street's somewhat bearish sentiment, what could be fueling the stock's seemingly unstoppable rally? I think the company's high short interest could be the cause of the rise in its stock. Per the chart above, roughly 35% of Hims & Hers float is sold short. Investors who short a stock are betting its price will fall. Short interest of 10% or more is considered unusually high. Not only is Hims & Hers' short interest much higher than the usual benchmarks, it's also rising. A high short interest can fuel volatility and even a rise in a stock's price if investors who are shorting a stock need to buy shares in the company to return the borrowed shares and close out their position. This is known as short covering, and it often leads to pronounced increases in a stock for a fleeting period of time, adding to volatility. You might be more familiar with these dynamics as a short squeeze. Despite notable subscriber growth and expanding markets, Hims & Hers stock exhibits too much volatility for my liking, and with that, comes a high degree of uncertainty. At first glance, I can understand what makes Hims & Hers look like an appealing investment. Telemedicine represents a compelling opportunity at the intersection of healthcare and technology, and Hims & Hers has certainly proven that it can consistently acquire users and monetize them. Moreover, the prospects that AI presents in the healthcare space more broadly shouldn't be discounted -- further validating the vision management has for Hims & Hers' long-term growth. Nevertheless, I struggle to look past the meme stock type of behavior exhibited here. While some investors have certainly made money owning this stock, I am suspicious if their profits were sparked by the right reasons. Said differently, I view Hims & Hers as more of a swing trading stock (timing is everything) as opposed to a sound long-term opportunity at this time. For these reasons, I would pass on Hims & Hers at the moment. While I'm intrigued by the company's potential, I think shares have run up considerably and would not be surprised to see some contraction in the share price sooner than later. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Bank of America is an advertising partner of Motley Fool Money. Citigroup is an advertising partner of Motley Fool Money. Adam Spatacco has positions in Palantir Technologies. The Motley Fool has positions in and recommends Bank of America, CrowdStrike, Hims & Hers Health, and Palantir Technologies. The Motley Fool has a disclosure policy. Is Hims & Hers Health a Smart Buy Right Now? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
After Hitting All-Time Highs This Year, Is Berkshire Hathaway a Buy Today?
Berkshire Hathaway is run by none other than Warren Buffett, arguably the greatest investor of our time. Berkshire's stock has outperformed the S&P 500 this year and hit all-time highs. Investors seem to like the company's diversity of businesses and its management, and view the stock as a flight to safety. 10 stocks we like better than Berkshire Hathaway › Once the Trump administration began to implement sweeping tariffs against major trading partners of the U.S. in April, investors, sensing a significant disruption in the market, ditched U.S. risk assets and ran for cover. They piled into cash, gold, and assets they believed could provide a port in the storm. One of those happened to be Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), one of the largest conglomerates in the world, run by arguably the world's best investor, Warren Buffett. Berkshire's stock was up nearly 10% (as of June 4), compared to the broader benchmark S&P 500's roughly 2% gain. Berkshire's stock also hit all-time highs earlier this year. Is the stock still a buy today? Aside from Buffett and his strong team of investing lieutenants and managers, one thing investors seem to like about Berkshire is the diversity of businesses under the large conglomerate's umbrella. Berkshire not only operates a massive stock portfolio, but also a large insurance business as the owner of Geico. The company also owns a slate of energy assets, the Burlington North Santa Fe Railroad, and a mortgage business, among others. It might be difficult for some of these sectors to operate alone, but together they provide diversity and have turned Berkshire into a juggernaut that generated over $89.5 billion of earnings in 2024. It also had $47.4 billion of operating earnings, which Buffett believes is a better metric for the company because it strips out volatile unrealized capital gains and losses. Another reason investors view Berkshire as a flight to safety is because of the company's massive cash hoard. Combined, Berkshire's cash, cash equivalents, short-term U.S. Treasury investments, and investments in fixed-maturity securities totaled an incredible $357 billion. Berkshire now reportedly owns about 5% of the short-term Treasury bill market. The massive pile of cash gives Berkshire a huge margin of safety -- and also a war chest, should opportunities arise in the market that Berkshire finds compelling. Now, after a strong run, it's always important to look at a stock's valuation. One way investors like to value Berkshire is on a price-to-tangible book value (TBV) basis, which is a frequent way investors value bank and insurance stocks. As you can see above, Berkshire's stock recently traded slightly under two times TBV. That's down from highs the stock reached earlier this year, but also above the company's five-year average. While Berkshire's stock does look a bit expensive right now, I still think long-term-oriented investors will be served well by owning it. For one, Buffett and his team have built Berkshire to last, meaning it can perform well through the entirety of the economic cycle, including the tougher parts. Berkshire's equities portfolio has exposure to growth stocks like tech and artificial intelligence, but management are also clearly big believers in oil and gas, which they may view as a finite resource. Not only does the company own and operate energy businesses, but Berkshire has major stakes in large domestic oil and gas producers like Occidental Petroleum and Chevron. These stocks should perform well if the price of oil, which trades in the low $60s per barrel, eventually rises. Investors may be concerned over the fact that Buffett, who is 94 years old, is preparing to retire at the end of 2025 after over six decades on the job. No one will ever be able to replace the Oracle of Omaha, but incoming CEO Greg Abel is more than capable. Without the Buffett brand, I think Berkshire may also try to entice investors by returning more capital to shareholders through stock repurchases and perhaps even a dividend, which Berkshire has never paid before. So even with the departure of Buffett, who will stay on as chair of the company's board of directors, it's not all doom and gloom. There is still much more for investors to look forward to. Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Bram Berkowitz has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway and Chevron. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy. After Hitting All-Time Highs This Year, Is Berkshire Hathaway a Buy Today? was originally published by The Motley Fool Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
4 hours ago
- Business Wire
BF-A, BF-B Investors Have Opportunity to Join Brown-Forman Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Brown-Forman Corporation ('Brown-Forman' or 'the Company') (NYSE: BF-A, BF-B) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Brown-Forman reported its financial results for fiscal year 2025 on June 5, 2025. The Company reported a decline in year-over-year sales of 7.3% and earnings per share below consensus estimates. The Company stated its "results did not meet our long-term growth aspirations," and advised investors that "looking ahead to fiscal 2026, we expect continued headwinds." If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
